全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:... Christophe Fermé , Vincent Ribrag , David Ghez
来源:[J].European Journal of Nuclear Medicine and Molecular Imaging(IF 5.114), 2017, Vol.44 (12), pp.2018-2024
摘要:Though commonly used to assess response to therapy, the prognostic value of interim FDG-PET/CT in Primary Mediastinal Large B-cell Lymphoma (PMBCL) is unclear.
作者:Vincent Ribrag , Laura Mezquita ...
来源:[J].European Journal of Cancer(IF 5.061), 2020, Vol.129, pp.71-79
摘要:Abstract(#br)Background(#br)Aging is an important risk factor for cancers and is associated with poor prognosis. Weakness of the immune system, also called immunosenescence may occur with older age. The impact of aging on efficacy and safety of immune checkpoint blockers, su...
作者:Vincent Ribrag , Sandrine Aspeslagh ...
来源:[J].European Journal of Cancer(IF 5.061), 2017, Vol.84, pp.212-218
摘要:Abstract(#br)Introduction(#br)Life expectancy evaluation is crucial when selecting patients who may benefit from phase I studies. The Royal Marsden Hospital (RMH) prognostic score, based on three objective variables (number of metastatic sites, lactate dehydrogenase (LDH) an...
作者:Vincent Ribrag , Jean-Charles Soria
来源:[J].European Journal of Cancer(IF 5.061), 2018, Vol.98, pp.17-22
摘要:Abstract(#br)Purpose(#br)Enrolment process influences the likelihood of patients' inclusion in early clinical trials (ECT) through social, medical and organisational factors.(#br)Patients and Methods(#br)All patients referred from 2008 to 2016 to the Drug Development Departm...
作者:Vincent Ribrag , Jean-Pierre Armand ...
来源:[J].European Journal of Cancer(IF 5.061), 2018, Vol.101, pp.160-164
摘要:Abstract(#br)Background(#br)Long-term responders have been observed with anti-programmed death 1 and anti-programmed death ligand 1 (anti-PD(L)1). Optimal duration of therapy in responding and stable disease (SD) patients is unclear with various attitudes encompassing treatm...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×